1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Global Upstream Bioprocessing Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Global Upstream Bioprocessing Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Upstream Bioprocessing Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Global Upstream Bioprocessing Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.1.1. Bioreactors/Fermenters
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Cell Culture Products
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Filters
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.Bags & Containers
11.3.1.4.1.By Value (USD Million) 2024A-2034F
11.3.1.4.2. Market Share (%) 2024A-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.5.Others
11.3.1.5.1.By Value (USD Million) 2024A-2034F
11.3.1.5.2. Market Share (%) 2024A-2034F
11.3.1.5.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Workflow
11.3.2.1.Cell Culture
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Cell Separation
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Media Preparation
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Others
11.3.2.4.1. By Value (USD Million) 2024A-2034F
11.3.2.4.2.Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Use Type
11.3.3.1.Multi-use
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Single-use
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.2.4.
11.3.4. By Mode
11.3.4.1.In-house
11.3.4.1.1.By Value (USD Million) 2024A-2034F
11.3.4.1.2. Market Share (%) 2024A-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.2. Outsource
11.3.4.2.1. By Value (USD Million) 2024A-2034F
11.3.4.2.2.Market Share (%) 2024A-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.5. By End-User
11.3.5.1.Biopharmaceutical companies
11.3.5.1.1.By Value (USD Million) 2024A-2034F
11.3.5.1.2. Market Share (%) 2024A-2034F
11.3.5.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.5.2. CDMO and CROs
11.3.5.2.1. By Value (USD Million) 2024A-2034F
11.3.5.2.2.Market Share (%) 2024A-2034F
11.3.5.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.5.3. Research and academic institutes
11.3.5.3.1. By Value (USD Million) 2024A-2034F
11.3.5.3.2.Market Share (%) 2024A-2034F
11.3.5.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.5.4. Others
11.3.5.4.1.By Value (USD Million) 2024A-2034F
11.3.5.4.2. Market Share (%) 2024A-2034F
11.3.5.4.3. Y-o-Y Growth (%) 2024A-2034F
12. North America Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Workflow
12.3.3.By Use Type
12.3.4.By Mode
12.3.5.By End-User
12.4. Country
12.4.1. United States
12.4.2.Canada
13. Europe Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Workflow
13.3.3.By Use Type
13.3.4.By Mode
13.3.5.By End-User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Workflow
14.3.3.By Use Type
14.3.4. By Mode
14.3.5.By End-User
14.4. Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Workflow
15.3.3.By Use Type
15.3.4.By Mode
15.3.5.By End-User
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Workflow
16.3.3.By Use Type
16.3.4.By Mode
16.3.5.By End-User
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Thermo Fisher Scientific Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2. Merck KGaA
18.3. Sartorius AG
18.4. Danaher Corporation
18.5. GE Healthcare
18.6. Lonza Group Ltd.
18.7. Eppendorf AG
18.8. Corning Incorporated
18.9. Applikon Biotechnology BV
18.10. PBS Biotech, Inc.
18.11.Novasep Holding SAS
18.12. Fujifilm Diosynth Biotechnologies (a subsidiary of Fujifilm Holdings Corporation)
18.13. MilliporeSigma (the Life Science business of Merck KGaA)
18.14. Bio-Rad Laboratories, Inc.
18.15. Repligen Corporation
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation
Select License Type
Our Clients
We have been working with some Fortune 500+ clients
.png){kind=icon}
